Revenue Breakdown
Composition ()
No data
Revenue Streams
Profitability & Margins
Evaluating the bottom line, RenovoRx Inc maintains a gross margin of 80.08%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -1203.01%, while the net margin is -1094.74%. These profitability ratios, combined with a Return on Equity (ROE) of -146.61%, provide a clear picture of how effectively RNXT converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, RNXT competes directly with industry leaders such as LTRN and SCYX. With a market capitalization of $32.32M, it holds a leading position in the sector. When comparing efficiency, RNXT's gross margin of 80.08% stands against LTRN's N/A and SCYX's 100.00%. Such benchmarking helps identify whether RenovoRx Inc is trading at a premium or discount relative to its financial performance.
